NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guérin therapy for bladder cancer. [electronic resource]
Producer: 20110727Description: 430-7 p. digitalISSN:- 1873-7560
- Administration, Intravesical
- Adult
- Aged
- Aged, 80 and over
- BCG Vaccine -- therapeutic use
- Biomarkers, Tumor -- genetics
- Cation Transport Proteins -- genetics
- Female
- Follow-Up Studies
- Glutathione Peroxidase -- genetics
- Humans
- Immunologic Factors -- administration & dosage
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local -- genetics
- Polymorphism, Restriction Fragment Length
- Predictive Value of Tests
- Prognosis
- Promoter Regions, Genetic -- genetics
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
- Glutathione Peroxidase GPX1
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.